\n On June 8, 2026, representatives of Vazyme visited LLP Scientific and Production Enterprise \u201cAntigen\u201d. During the meeting, the parties discussed prospects for cooperation in the fields of molecular biology, molecular diagnostics and the application of modern laboratory reagents.\n<\/p>\n\n
\n Vazyme is an international biotechnology company specializing in the development, manufacturing and application of bioactive proteins, reagents and solutions for life science, in vitro diagnostics, biomedicine and laboratory research. The company\u2019s portfolio includes polymerase chain reaction (PCR) reagents, nucleic acid extraction kits, enzymes, molecular biology products, next-generation sequencing solutions and other laboratory tools.\n <\/p>\n\n
\n During the meeting, specialists of LLP SPE \u201cAntigen\u201d and representatives of Vazyme discussed the use of reagents for PCR and real-time PCR, optimization of molecular diagnostic workflows, DNA and RNA extraction, and the potential application of modern technological solutions in the company\u2019s research and production activities.\n <\/p>\n\n
\n Special attention was given to possible cooperation in veterinary molecular diagnostics, laboratory control of infectious diseases, exchange of technical information, consulting support and further professional interaction between specialists.\n <\/p>\n\n
\n The meeting became an important step in strengthening the international scientific and technical cooperation of LLP SPE \u201cAntigen\u201d and provided an opportunity to discuss new approaches in the field of molecular biological research.\n <\/p>\n\n
\n In the future, the parties plan to continue discussing potential areas of cooperation, including the supply and testing of reagents, technical support, specialist training and joint initiatives in laboratory diagnostics.\n <\/p>\n<\/div>\n\n